Hashimoto's disease, an autoimmune thyroid condition affecting approximately 5% of Americans, often leads to hypothyroidism and challenging weight gain despite standard levothyroxine therapy
At the same time, the industries are developing various such drug candidates to identify new applications of GLP-1 drugs
In Q1 2026, Amgen announced a SWITCH study enrolling 300 patients transitioning from weekly semaglutide or tirzepatide to MariTide on less frequent schedules, positioning the drug as a potential maintenance or step-down therapy
If the BALANCE Model launches in some future year with at least 80% participation, Part D plans could drop out of the model before the final year (originally 2031), which could interrupt treatment, or require frequent plan changes for Medicare Part D enrollees to maintain access
If you are already dealing with nausea, vomiting, or diarrhea, your doctor may choose an antibiotic less likely to worsen these symptoms or may recommend anti-nausea medications
Hispano Medical Centers adjusts medication dosages to match your requirements, which helps you achieve faster results